Pharmaceutical company Roche has revealed that several late-stage trials run for its multiple sclerosis drug, Ocrelizumab, have proven to be more promising and...
Pharmaceutical company Roche has revealed that several late-stage trials run for its multiple sclerosis drug, Ocrelizumab, have proven to be more promising and...